Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
56.34-0.15 (-0.27%)
At close: 04:00PM EDT
54.15 -2.19 (-3.89%)
After hours: 07:55PM EDT
Advertisement
Sign in to post a message.
  • D
    Dan
    Market will recognize this sector is less associated with inflation and war
  • s
    spacebee
    Here’s how people got wiped on GME. Trying to stay short until bankruptcy, when bankruptcy wasn’t on the table. Now I see a bunch of biotech with high short interest at all time lows. Some biotech is now under $500 mil market cap but they don’t have debt, How much lower do you want? There’s a bunch $NVTA $BLI $CRSP, etc
    Bullish
  • S
    Simon
    The news wire shows another strategic hire of Dr. P.K Morrow for the final stretch to regulatory approval. Don't miss this important clue. Go CRSP, Goodluck to All CRSP faithful.
    Bullish
  • J
    James
    Data to be presented at EHA. The abstract, as of December 6, 15 of the 17 patients with T-cell lymphoma were able to be evaluated with CTX130. The overall response rate was 71% with 29% of patients experiencing a complete response. It had an acceptable safety profile.
  • A
    AlabamaHobo
    after selling at $63 at loss i bought twice amount of shares in $44.

    Lets hope it does not look back anymore.
  • C
    ChrisP
    Green
  • R
    Rich
    Question: If gene editing is one-and-done, does the longer-term revenue stream from an effective therapy come only from new patients?
  • B
    Brian
    To invest in a company and make money is great. To invest in a company that cures diseases is heavenly.
  • S
    Simon
    CRSP stock price below $50 is a giveaway and a no brainer. Load up if you can and you'll be glad by end of the year.
    Bullish
  • b
    b
    $CRSP is one of my favorite stocks in $ARKG ... so I decided to just buy this at the open instead of ARKG.
  • J
    James
    6 on going clinical trials going on, and the analyst move price targets down.
  • D
    Dan
    With 2.2 billion cash with 3.5 bill mc, time to accumulate
  • e
    eric
    CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the 2022 Bank of America Healthcare Conference on Wednesday, May 11, 2022, at 4:40 p.m. PT.
  • R
    R
    Can you say "over-emotional panic selling?" It was just insane that this dumped all the way to the low $40s. I wasn't really expecting this to become a core holding of mine. But when it crashed last week, without too much thought I just bought shares in the chaos.
    Bullish
  • V
    VELAZQUEZPEREZ
    Can’t find the right stocks to trade? I have the fix for free (http://traderspot.club)
  • C
    Cnote
    Cost basis is 125…wake me up in 5 years
  • Z
    ZIM
    "WHERE IS CRSP EARNINGS????"
    CRISPR THERAPEUTICS IS IN THE RESEARCH & DEVELOPEMENT STAGE.
    APPLYING FOR FDA APPROVAL, 4TH QTR FOR CTX001

    CRSP / CRBU / NTLA
    SUPPORT THE NOBEL LAUREATES.
    NOT THE BROAD
    Bullish
  • F
    Frank
    It’s time to get loaded
Advertisement
Advertisement